Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.22%30.88B | 11.77%150.53B | 11.30%29.63B | -8.26%134.68B | 4.80%45.79B | -20.85%25.36B | -14.45%36.92B | -4.66%26.62B | 12.32%146.8B | 14.75%43.69B |
| Cost of revenue | 4.03%18.47B | 10.22%88.08B | 15.17%17.75B | -5.94%79.92B | 8.78%27.22B | -18.25%14.9B | -13.17%22.39B | -3.29%15.42B | 9.36%84.97B | 14.83%25.02B |
| Gross profit | 4.50%12.41B | 14.04%62.45B | 5.98%11.87B | -11.44%54.76B | -0.54%18.57B | -24.29%10.46B | -16.35%14.53B | -6.47%11.2B | 16.65%61.83B | 14.64%18.67B |
| Operating expense | 0.45%7.83B | 11.19%32.75B | 12.05%7.79B | 7.74%29.45B | 4.66%7.64B | 17.21%7.47B | 0.19%7.39B | 10.58%6.95B | 10.77%27.34B | 2.33%7.3B |
| Operating profit | 12.22%4.58B | 17.37%29.7B | -3.95%4.08B | -26.63%25.31B | -3.87%10.92B | -59.77%3B | -28.57%7.14B | -25.30%4.25B | 21.77%34.5B | 24.24%11.36B |
| Net non-operating interest income (expenses) | -6.67%-32M | -130.00%-138M | -114.29%-30M | -1,400.00%-60M | -525.00%-25M | -333.33%-7M | -14M | -366.67%-14M | 50.00%-4M | -233.33%-4M |
| Non-operating interest income | 350.00%18M | 42.22%64M | -60.00%4M | 25.00%45M | 20.00%12M | 10.00%11M | 33.33%12M | 42.86%10M | -14.29%36M | -28.57%10M |
| Non-operating interest expense | 47.06%50M | 92.38%202M | 41.67%34M | 162.50%105M | 164.29%37M | 157.14%18M | 188.89%26M | 140.00%24M | -20.00%40M | 27.27%14M |
| Net investment income | -148.37%-104M | -98.35%11M | -42.97%215M | 137.37%667M | 29.07%222M | 88.25%-39M | 2,040.00%107M | -13.53%377M | -53.63%281M | -63.17%172M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 33.88%245M | 0 | -14.49%183M | -38.10%26M | 37M | 1M | -30.81%119M | 756.00%214M | 68.00%42M | |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -70.00%3M | 478.03%4.16B | 116.39%10M | 135.56%719M | 353.53%791M | 99.77%-4M | -111.86%-7M | -1,625.00%-61M | -712.73%-2.02B | -198.11%-312M |
| Less:Other special charges | 70.00%-3M | -478.03%-4.16B | -116.39%-10M | -139.12%-719M | -717.97%-791M | -99.77%4M | 111.86%7M | 1,625.00%61M | 609.14%1.84B | 136.68%128M |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 493.55%184M | ---- |
| Other non-operating income (expenses) | -71.67%17M | -32.04%297M | -4.76%60M | 30.06%437M | 446.67%246M | -72.00%7M | 83.33%121M | -68.50%63M | 43.59%336M | -6.25%45M |
| Income before tax | 2.90%4.47B | 25.76%34.28B | -8.38%4.34B | -18.16%27.26B | 7.75%12.18B | -44.31%2.99B | -27.43%7.35B | -27.16%4.74B | 12.82%33.3B | 12.98%11.31B |
| Income tax | 62.86%1.23B | 9.50%8.53B | -48.21%754M | -18.90%7.79B | 17.90%3.44B | -55.37%898M | -33.79%2B | -12.29%1.46B | 18.14%9.61B | -4.05%2.92B |
| Net income | -9.71%3.24B | 32.27%25.74B | 9.33%3.59B | -17.85%19.46B | 4.22%8.74B | -37.69%2.09B | -24.71%5.35B | -32.28%3.28B | 10.80%23.69B | 20.39%8.39B |
| Net income continuous operations | -9.71%3.24B | 32.26%25.74B | 9.30%3.59B | -17.85%19.46B | 4.22%8.74B | -37.68%2.09B | -24.73%5.35B | -32.26%3.28B | 10.80%23.69B | 20.41%8.39B |
| Noncontrolling interests | -77.42%7M | 26.19%106M | -6.06%31M | 35.48%84M | -433.33%-20M | 38.89%25M | 411.11%46M | 13.79%33M | 8.77%62M | 20.00%6M |
| Net income attributable to the company | -9.14%3.23B | 32.30%25.64B | 9.52%3.55B | -17.99%19.38B | 4.52%8.76B | -38.08%2.07B | -25.27%5.3B | -32.56%3.25B | 10.80%23.63B | 20.39%8.38B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -9.14%3.23B | 32.30%25.64B | 9.52%3.55B | -17.99%19.38B | 4.52%8.76B | -38.08%2.07B | -25.27%5.3B | -32.56%3.25B | 10.80%23.63B | 20.39%8.38B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -8.42%79.77 | 31.90%633.75 | 8.02%87.1 | -17.35%480.49 | 5.19%217.16 | -37.62%51.16 | -24.61%131.54 | -31.89%80.63 | 11.26%581.33 | 20.66%206.45 |
| Diluted earnings per share | -0.80%79.14 | 32.16%628.31 | 0.00%79.78 | -17.41%475.42 | 5.15%214.88 | -37.64%50.63 | -24.68%130.13 | -31.98%79.78 | 11.23%575.62 | 20.60%204.36 |
| Dividend per share | 0 | 31.77%253 | 0 | -18.30%192 | -18.25%103 | 0 | -18.35%89 | 0 | 27.03%235 | 24.75%126 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |